Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Did Merck Spend $4 Billion on a Tiny Biotech Firm?
Wall St Cheat Sheet
Saturday, June 14, 2014 - 9:33am
tags:
Merck, Idenix
Results from Phase III Study (AML-001) of VIDAZA® (Azacitidine for Injection) in Acute Myeloid Leukemia Presented at EHA
Yahoo/BusinessWire
Saturday, June 14, 2014 - 9:29am
tags:
acute myeloid leukemia, leukemia, Vidaza, Celgene
New Agios Clinical Data from Ongoing Phase 1 Trial of AG-221 Continue to Show Complete and Durable Remissions in Patients with Difficult to Treat Hematologic Malignancies
Yahoo/BusinessWire
Saturday, June 14, 2014 - 9:27am
tags:
hematologic cancers, Agios Pharmaceuticals, AG-221
Is It Time to Buy Geron?
Motley Fool
Saturday, June 14, 2014 - 9:23am
tags:
Geron
Vantictumab Placed on Partial Clinical Hold by FDA Following Voluntary Halt by OncoMed
Yahoo/Globe Newswire
Saturday, June 14, 2014 - 9:22am
tags:
vantictumab, OncoMed
Is It Time to Buy Orexigen?
Motley Fool
Saturday, June 14, 2014 - 9:20am
tags:
Orexigen
AstraZeneca Boosts Pipeline with $232 Million Synairgen Deal
Yahoo/Zacks
Saturday, June 14, 2014 - 9:18am
tags:
AstraZeneca, Synairgen, SNG001
Should Pfizer Buy Eli Lilly?
Motley Fool
Friday, June 13, 2014 - 6:52pm
tags:
Pfizer, Eli Lilly, M&A, AstraZeneca
Vivus hits Actavis with Qsymia patent-infringement lawsuit
Fierce Pharma
Friday, June 13, 2014 - 6:46pm
tags:
patents, Vivus, Qsymia, Actavis, generics
Enanta notes AbbVie granted FDA priority review for Hep C combo regimen
Yahoo/Fly on the Wall
Friday, June 13, 2014 - 6:44pm
tags:
AbbVie, Enanta Pharmaceuticals, FDA, hepatitis C, ABT-450
Pharma Sales Reps See Salaries Climb
ePharma Summit
Friday, June 13, 2014 - 3:15pm
tags:
drug reps, salaries
Arena's Belviq Sales Do More Than Recover
Seeking Alpha
Friday, June 13, 2014 - 3:05pm
tags:
Arena Pharmaceuticals, Belviq, obesity, Orexigen, Contrave
MannKind Entertaining Multiple Partnership Possibilities Ahead Of FDA Decision On Afrezza
Seeking Alpha
Friday, June 13, 2014 - 12:28pm
tags:
MannKind, FDA, Afrezza, diabetes
Diabetes: The $54 billion battleground
CNBC
Friday, June 13, 2014 - 12:26pm
tags:
diabetes, Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca
What Is Next For The Hepatitis C Space?
Seeking Alpha
Friday, June 13, 2014 - 11:05am
tags:
hepatitis C, Conatus Pharmaceuticals, Gilead Sciences, Merck, Idenix
Apple's Venture Into Mobile Medical Applications: A Game Changer?
Seeking Alpha
Friday, June 13, 2014 - 11:03am
tags:
Apple, mHealth, Google
Galena Promoting Experimental Breast Cancer Drug With Faux News Articles Again
TheStreet.com
Friday, June 13, 2014 - 11:00am
tags:
Galena Biopharma, breast cancer, SEC, NeuVax
What Will Happen When Biotech Drugs Go Generic?
Forbes
Friday, June 13, 2014 - 10:58am
tags:
biotech, generics, Amgen, Roche, Biogen Idec, Eli Lilly, Bristol-Myers Squibb, Sanofi, Novartis, Sandoz, Omnitrope, Genotropin
Drug-linked payouts - complex fix for Pfizer's next Astra bid?
Yahoo/Reuters
Friday, June 13, 2014 - 10:55am
tags:
Pfizer, AstraZeneca, M&A
Spooked by probes, pharma executives ask: should I leave China?
Yahoo/Reuters
Friday, June 13, 2014 - 10:48am
tags:
China

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.